IL-3 Is a Novel Target to Interfere With Tumor Vasculature
Oncogene - United Kingdom
doi 10.1038/onc.2011.204
Full Text
Open PDFAbstract
Available in full text
Date
June 6, 2011
Authors
Publisher
Springer Science and Business Media LLC
Available in full text
June 6, 2011
Springer Science and Business Media LLC